Fluenz
influenza vaccine (live attenuated, nasal)
Influenza, Human
Opinion date:
Last updated:
MedicineHumanOpinion
EMEA-003100-PIP01-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Neurology
PIP number: P/0522/2022
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Concentrate for solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-003214-PIP01-22 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Ophthalmology
PIP number: P/0283/2022
Route(s) of administration: Intravitreal use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Fluenz Tetra
influenza vaccine (live attenuated, nasal)
Influenza, Human
Date of authorisation:
Revision: 24
Last updated:
MedicineHumanAuthorised
Fluenz
influenza vaccine (live attenuated, nasal)
Influenza, Human
Immunization
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanWithdrawn
EMEA-000249-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Vaccines
PIP number: P/14/2011
Route(s) of administration: Intranasal use
Pharmaceutical form(s):
Nasal spray suspension
Decision date:
Last updated:
Compliance check: ✖
PIPHuman